Actively Recruiting

Phase Not Applicable
Age: 30Years - 45Years
All Genders
NCT07231484

Effects of Grape Consumption on the Immune-Gut Axis in Obesity

Led by University of Missouri-Columbia · Updated on 2025-12-30

50

Participants Needed

1

Research Sites

105 weeks

Total Duration

On this page

Sponsors

U

University of Missouri-Columbia

Lead Sponsor

C

California Table Grape Commission

Collaborating Sponsor

AI-Summary

What this Trial Is About

This study is investigating the benefits of whole freeze-dried grape powder consumption on the immune-gut axis in adults with obesity.

CONDITIONS

Official Title

Effects of Grape Consumption on the Immune-Gut Axis in Obesity

Who Can Participate

Age: 30Years - 45Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Age between 30 and 45 years
  • Obesity with a BMI of 30 to 45 kg/m2
  • Willingness to consume study foods
  • Consistent diet and physical activity patterns for at least 4 weeks
  • Stable body weight with less than 5 kg change in the last 3 months
  • Non-smoker for at least 1 year
  • Not currently following an extremely healthy diet
Not Eligible

You will not qualify if you...

  • Allergy to study foods
  • Regular consumption of grapes or grape-derived products
  • Gastrointestinal disease or history of bariatric surgery
  • Uncontrolled hypertension with blood pressure over 180/110
  • Diagnosis of diabetes
  • Clinical depression
  • Use of illicit drugs
  • History of alcohol or drug abuse
  • Recent use of medications affecting immune function, such as corticosteroids
  • Recent use of antibiotics, prebiotics, probiotics, symbiotics, or dietary supplements with fiber or phytochemicals
  • Pregnant or breastfeeding
  • HIV positive
  • Recent start of medications affecting metabolism or appetite
  • Current drug treatment for coronary artery disease, peripheral artery disease, congestive heart failure, or dyslipidemia

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

University of Missouri-Columbia

Columbia, Missouri, United States, 65211

Actively Recruiting

Loading map...

Research Team

J

Jaapna Dhillon PhD, PhD

CONTACT

C

Caitlyn Winn, MS

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

SINGLE

Allocation

RANDOMIZED

Model

CROSSOVER

Primary Purpose

TREATMENT

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here